Real-world treatment utilization and effectiveness of onabotulinumtoxinA in multiple sclerosis patients treated for spasticity from the ASPIRE study

被引：0
|
作者：
Bandari, D. S. [1 ,2 ]
Mayadev, A. [3 ]
Sakel, M. [4 ]
Esquenazi, A. [5 ]
Zuzek, A. [6 ]
Largent, J. [7 ]
Francisco, G. E. [8 ,9 ]
机构：
[1] Hoag Neurosci Inst, Multiple Sclerosis Ctr Calif, Newport Beach, CA USA
[2] Hoag Neurosci Inst, Res Grp, Newport Beach, CA USA
[3] Swedish Neurosci Inst, Multiple Sclerosis Ctr Rehabil Program, Seattle, WA USA
[4] Kent & Canterbury Hosp, East Kent Hosp Univ NHS Fdn, Caterbury, England
[5] MossRehab Gait & Mot Anal Lab, Elkins Pk, PA USA
[6] Allergan Plc, Irvine, CA USA
[7] IQVIA Real World Evidence Solut, Cambridge, MA USA
[8] Univ Texas McGovern Med Sch, Houston, TX USA
[9] TIRR Mem Hermann, Houston, TX USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P640
引用
收藏
页码：321 / 322
页数：2
相关论文
共 50 条
  • [1] Real-World Treatment Utilization and Effectiveness of OnabotulinumtoxinA in Multiple Sclerosis Patients Treated for Spasticity From the ASPIRE Study
    Bandari, Daniel S.
    Mayadev, Angeli
    Sakel, Mohamed
    Esquenazi, Alberto
    Zuzek, Aleksej
    Largent, Joan
    Francisco, Gerard E.
    TOXICON, 2022, 214 : S6 - S6
  • [2] THE ADULT SPASTICITY INTERNATIONAL REGISTRY (ASPIRE) STUDY: REAL-WORLD TREATMENT UTILIZATION AND EFFECTIVENESS OF ONABOTULINUMTOXINA IN POST-STROKE PATIENTS TREATED FOR SPASTICITY
    Bavikatte, G.
    Francisco, G. E.
    Bandari, D. S.
    Jost, W. H.
    Zuzek, A.
    Largent, J.
    Esquenazi, A.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 17 - 17
  • [3] Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study
    Esquenazi, Alberto
    Francisco, Gerard E.
    Feng, Wuwei
    Baricich, Alessio
    Gallien, Philippe
    Fanning, Kristina
    Zuzek, Aleksej
    Bandari, Daniel S.
    Wittenberg, George F.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2021, 102 (11): : 2172 - +
  • [4] Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study
    Esquenazi, A.
    Feng, W.
    Wittenberg, G.
    Gallien, P.
    Baricich, A.
    Fanning, K.
    Zuzek, A.
    Francisco, G.
    Bandari, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 632 - 632
  • [5] The Adult Spasticity International Registry (ASPIRE) Study: treatment utilization patterns in patients with multiple sclerosis patients treated for spasticity
    Bandari, D.
    Mayadev, A.
    Esquenazi, A.
    Adams, A. M.
    Francisco, G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 671 - 671
  • [6] ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY
    Esquenazi, Alberto
    Feng, Wayne
    Wittenberg, George F.
    Gallien, Phillipe
    Baricich, Alessio
    Fanning, Kristina
    Zuzek, Aleksej
    Francisco, Gerard E.
    Bandari, Daniel S.
    TOXICON, 2021, 190 : S23 - S23
  • [7] Comparison of OnabotulinumtoxinA Utilization and Effectiveness Across Various Etiologies of Spasticity from the Adult Spasticity International Registry Study: ASPIRE
    Francisco, Gerard
    Bandari, Daniel
    Bavikatte, Ganesh
    Jost, Wolfgang
    Zuzek, Aleksej
    Largent, Joan
    Esquenazi, Alberto
    NEUROLOGY, 2018, 90
  • [8] Comparison of OnabotulinumtoxinA Utilization and Effectiveness across Various Etiologies of Spasticity from the Adult Spasticity International Registry Study: ASPIRE
    Gerard, Francisco
    Bandari, Daniel
    Bavikatte, Ganesh
    Jost, Wolfgang
    Zuzek, Aleksej
    Largent, Joan
    Esquenazi, Alberto
    MOVEMENT DISORDERS, 2018, 33 : S58 - S59
  • [9] Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE
    Esquenazi, A.
    Feng, W.
    Wittenberg, G.
    Gallien, P.
    Baricich, A.
    Fanning, K.
    Zuzek, A.
    Francisco, G.
    Bandari, D.
    MOVEMENT DISORDERS, 2020, 35 : S588 - S589
  • [10] Individualized Onabotulinumtoxina Treatment for Spasticity in Multiple Sclerosis Resulted in High Patient and Clinician Satisfaction: The Aspire Study
    Bandari, Daniel S.
    Mayadev, Angeli
    Sakel, Mohamed
    Esquenazi, Alberto
    Largent, Joan
    Zuzek, Aleksej
    Francisco, Gerard E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 153 - 154
12345